BRENZYS

Approval Id: 464bf7a8ad3759f5
Drug Approval Canada Name: BRENZYS
Product Name: BRENZYS
Status: Marketed
Status Date: 2016-09-13
Original Market Date: 2016-09-13
Din: 02455331
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Schedule D , Prescription
Ahfs: 90:24.16.92
Atc Original: L04AB01 ETANERCEPT
Atc Name: l 04 ab 01
Aig Number: 0151564001
Company Name: Samsung Bioepis Co., Ltd.
Company Address: 76, Songdogyoyuk-Ro, Yeonsu-Gu, Incheon, Incheon, Korea, Republic Of, 21987
Company Detail Path: /organization/samsung-bioepis-co-ltd

ETANERCEPT

50 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

464bf7a8ad3759f5

Type

Standard